Torrent Pharma inks licensing pact with Takeda to commercialise GERD drug

Torrent Pharmaceuticals on Wednesday said it has entered a non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan in India. Vonoprozan is a novel potassium-competitive acid blocker (P-CAB), used for the treatment of acid related disorders gastroesophageal reflux disease.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/efJ1RhC
via IFTTT

0 comments:

Post a Comment